Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.260
+0.110 (3.49%)
At close: Aug 11, 2026, 4:00 PM EDT
3.251
-0.009 (-0.29%)
After-hours: Aug 11, 2026, 7:52 PM EDT
Prime Medicine Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Prime Medicine stock has a consensus rating of "Buy" and an average price target of $7.03. The average 1-year stock price forecast is 115.64% higher than the current stock price, while the lowest is $4.25 (+30.37%) and the highest is $11 (+237.42%).
Price Target: $7.03 (+115.64%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Prime Medicine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 9 | 9 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $8 | Buy | Maintains | $8 | +145.40% | Aug 10, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $5 | Buy | Maintains | $5 | +53.37% | Aug 6, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $6 | Buy | Maintains | $6 | +84.05% | Aug 6, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $11 | Buy | Reiterates | $11 | +237.42% | Jul 24, 2026 |
Financial Forecast
Revenue This Year
10.79M
from 4.63M
Increased by 132.94%
Revenue Next Year
11.58M
from 10.79M
Increased by 7.31%
EPS This Year
-0.93
from -1.35
EPS Next Year
-0.89
from -0.93
EPS and Forward PE are based on non-GAAP adjusted numbers.